- Home
- / Cardiol Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Cardiol Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$3.4
2021-10-11
Market Capitalization
$98.2 M
2021-10-11
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 79.0K | |||||||
| Gross profit | 7.0K | 79.0K | ||||||
| Gross profit margin, % | 100.0% | |||||||
| Operating expense total | 7.7M | 14.0M | 20.5M | 38.5M | 41.1M | 29.8M | 40.3M | 34.3M |
| Depreciation and amortization | 91.0K | 150.0K | 229.0K | 220.0K | 220.0K | |||
| EBITDA | (7.7M) | (14.0M) | (20.5M) | (38.4M) | (41.1M) | (29.8M) | (40.3M) | (34.3M) |
| EBITDA margin, % | -48663.3% | |||||||
| EBIT | (8.2M) | (13.8M) | (20.7M) | (38.6M) | (41.2M) | (29.6M) | (40.2M) | (34.3M) |
| EBIT margin, % | -48800.0% | |||||||
| Interest income | 103.0K | 245.0K | 76.0K | 106.0K | 1.2M | 2.0M | 1.2M | 726.0K |
| Pre tax profit | (15.9M) | (13.7M) | (20.6M) | (31.6M) | (30.9M) | (28.1M) | (36.7M) | (33.8M) |
| Net Income | (15.9M) | (13.7M) | (20.6M) | (31.6M) | (30.9M) | (28.1M) | (36.7M) | (33.8M) |